<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) is a <z:hpo ids='HP_0011010'>chronic</z:hpo>, <z:hpo ids='HP_0003676'>progressive disorder</z:hpo> that affects many systems of the body including the eye </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to examine the effects of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase activity (NOS), nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO*), and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) levels in patients with active BD </plain></SENT>
<SENT sid="2" pm="."><plain>Included in this study were 18 male BD patients and 16 male healthy volunteers as controls </plain></SENT>
<SENT sid="3" pm="."><plain>Erythrocyte NOS activity, (NO*) erythrocyte sedimentation rate, serum C-reactive protein, and plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> values in the patients with BD were significantly higher than those of the control group </plain></SENT>
<SENT sid="4" pm="."><plain>Our results show that these parameters play a major role in the inflammatory reactions observed in BD </plain></SENT>
</text></document>